MASH Matters: The Evolving Management of Patients with Metabolic Dysfunction Associated Steatohepatitis

Nov 17 2024
Convention Center: Exhibit Hall B - TLM Theater 1
1:30 PM - 2:00 PM

Description

MASH prevalence is rapidly increasing in parallel with increases in obesity and other cardio-renal-metabolic diseases. An interactive case will explore clinical challenges and unmet patient needs.

Industry Supporter: Boehringer Ingelheim International GmbH

Presentations

9:01 AM - 9:01 AM
Nov 17 2024
San Diego, CA

MASH Matters: The Evolving Management of Patients with Metabolic Dysfunction Associated Steatohepatitis

Kris V Kowdley, MD, FACP, FACG, AGAF, FAASLD, Industry Presenter